SynthesisFrontiers in oncology2025
A scientometric analysis of global research on gut microbiota and glioma.
Synthesis in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Most previous studies have demonstrated that gut microbiota is closely related to the prognosis of glioma. However, there is currently no corresponding bibliometric analysis to systematically review, analyze, and visualize prior research. Materials & methods: This study focused on 127 publications obtained from the Web of Science Core Collection and conducted correlation analyses of authors, journals, institutions, countries, keywords, and citations using VOSviewer, CiteSpace, and the R package. Results: The results indicate that China and the United States are the leading countries conducting research in this field. The Anderson Cancer Center at the University of Texas in the United States and Central South University in China are the primary research institutions. Discussion: Recent studies suggest that the regulation of the brain-gut axis between gut microbiota and glioma remains a prominent research hotspot, while the anti-cancer mechanisms of the enteric nervous system and gut microbiota have emerged as significant topics in recent years. Furthermore, the receptor tyrosine kinase pathway is expected to provide extensive research opportunities in the future. This article systematically reviews the current research status and hotspots of gut microbiota in glioma for the first time, conducts a visual analysis, and explores research trends and future directions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.